跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HAT-1
首页
药物
HAT-1
HAT-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMBINATION OF SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR USE IN TREATING A HEMATOLOGICAL MALIGNANCY
EP 4048260 C0
申请人: CELGENE CORP
优先权: 2019
CN
EP
US
WO
9 件公开
Polyisoprenylated benzophenones and their isomers as inhibitors of histone acetyltransferases and uses thereof
US 7402706 B2
申请人: JAWAHARLAL NEHRU CT FOR ADVANC
优先权: 2003
US
2 件公开
Cancer chemotherapy employing halogenated analogs of thymidine
US 10278983 B2
申请人: ORDAHL CHARLES
优先权: 2016
US
2 件公开
Conjugated organic lithium ion battery electrode material and preparation method and application thereof
CN 111440179 A
申请人: UNIV QUJING NORMAL
优先权: 2020
CN
2 件公开
Antibody to hepatocyte growth factor activator inhibitor-1 and use thereof
US 2003064420 A1
申请人: YAMAGISHI TOSHIYA
优先权: 2001
US
Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket
CN 101129353 B
申请人: BEIJING SHENOGEN PHARMACEUTICAL TECHNOLOGY CO LTD
优先权: 2007
CN
Medicine cap capable of treating encephalatrophy and manufacture method thereof
CN 101507856 A
申请人: LANGHUI LI
优先权: 2008
CN
Anti-rabbit hemorrhagic disease virus VP60 albumen monoclonal antibody
CN 101519447 A
申请人: JIANGSU ACAD AGRICULTURAL SCI
优先权: 2009
CN
Hybridoma cell strain F3
CN 101899111 A
申请人: UNIV NANJING AGRICULTURAL
优先权: 2010
CN
Hybridoma cell line D6D
CN 101906159 B
申请人: UNIV NANJING AGRICULTURAL
优先权: 2010
CN
第 1 / 4 页
上一页
下一页
药物
反馈